CD44 and cancer: To cope with the hypoxic environment around CSC, Ning et al. designed a CD44 targeting type one aggregation-induced emission photosensitizer-loaded biomimetic mesoporous organosilicon nano-system to prevent cancer recurrence after radiotherapy [117].